Drug shortage
Clindamycin Phosphate Injection · Sandoz Inc.
FDA drug shortage · Current · updated Apr 16, 2025
Key facts
| Generic name | Clindamycin Phosphate Injection |
|---|---|
| Proprietary name | Clindamycin Phosphate In 5% Dextrose In Plastic Container |
| Company | Sandoz Inc. |
| Presentation | Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09) |
| Dosage form | Injection |
| Strength | 18 mg/1 mL |
| Status | Current |
| Therapeutic category | Anti-Infective |
| Package NDCs | 0781-3290-09 |
| First posted | Mar 21, 2023 |
| Last updated | Apr 16, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: